Conference abstract · 3 Aug 2015
Conference abstractPublished 23 Nov 2012
Comparative study of regulatory guidelines - bio analytics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rapid growth in pharmaceutical spending is a worldwide phenomenon. According to a study, spending on pharmaceuticals in OECD (organization for economic cooperation & development) countries has an increase by an average of 32%in 1998 & in 2003 it was more than U.S$450billon. The regulation of pharmaceuticals aims to control manufacturing standards, quality, efficacy & safety of drugs, labeling & information requirements, distribution procedures and consumer prices. Here comes the role of drug price control, as India is known for it?s reverse engineering, we are now current net exporter of quality & cheap generic drugs across the global market & India is a global competitor in advanced life sciences. Price control mechanisms for pharmaceutical products are a common form of intervention in many countries to control the costs of healthcare. The principal methods employed in many countries include pharmacoeconomics, various forms of reference pricing, comparator pricing, restrictions on dispensing and prescribing, and reimbursement restrictions. Canada uses the two-tiered pricing system based on negotiated prices while France follows new price notification procedure - to be set up with reference to prices based on a European average. The present work deals with impact of regulations pertaining to economy of pharmaceuticals.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2023
Pharmaceutical and Analytical Study of Gandharva Haritaki Prepared by Murchhit and Amurchhit Erand Tail and Comparative Assessment for Invitro Bio-Accessibility
Article · 29 Jun 2025
Regulatory Guidelines in Drug Development and Approval
Review article · 3 May 2019
Review on Technology Transfer as a Regulatory Aspect with Inclusion of ICH Guidelines
Conference abstract · 3 Aug 2015
Need for uniform regulatory guidelines for toxicity evaluation of nanomaterials
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Madhusudhan Yenugula”
- BylineArticles whose byline prints “Rambabu Siripothula”
- BylineArticles whose byline prints “M. Mathrusri Annapurna”

